HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert A O'Rourke Selected Research

Percutaneous Coronary Intervention

3/2016Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
8/2012Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.
4/2012Effectiveness of percutaneous coronary intervention in patients with silent myocardial ischemia (post hoc analysis of the COURAGE trial).
7/2011Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
3/2011The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
3/2010Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
12/2009Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.
10/2009Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
9/2009Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
7/2009Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert A O'Rourke Research Topics

Disease

9Coronary Artery Disease (Coronary Atherosclerosis)
03/2016 - 04/2007
7Coronary Disease (Coronary Heart Disease)
03/2016 - 04/2007
3Ischemia
08/2012 - 09/2006
3Stable Angina
03/2011 - 08/2008
3Myocardial Infarction
07/2009 - 04/2007
2Myocardial Ischemia (Ischemic Heart Diseases)
08/2012 - 04/2012
2Pathologic Constriction (Stenosis)
12/2011 - 07/2009
1Disease Progression
12/2011
1Hypertension (High Blood Pressure)
07/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2011
1Chronic Renal Insufficiency
12/2009
1Hypotension (Low Blood Pressure)
09/2009
1Acute Coronary Syndrome
07/2009
1Stroke (Strokes)
07/2009

Drug/Important Bio-Agent (IBA)

1boldenone undecylenate (Equipoise)IBA
08/2012
1Glucose (Dextrose)FDA LinkGeneric
07/2011
1HDL CholesterolIBA
07/2011
1lipoprotein cholesterolIBA
09/2009

Therapy/Procedure

17Therapeutics
03/2016 - 09/2006
13Percutaneous Coronary Intervention
03/2016 - 04/2007
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
07/2009 - 09/2008
1Secondary Prevention
03/2010